Polarised Poland: On politics, the Presidential election results
When Donald Tusk's diverse coalition came to power in Poland in 2023, ending the eight-year rule of the right-wing Law and Justice Party (PiS), the veteran centrist promised 'to chase away the darkness'. Two years on, with the Tusk government still struggling to deliver on key reforms, Polish voters have elected a conservative backed by PiS as the country's next President. Karol Nawrocki, a 42-year-old historian and former boxer with little political experience, won the June 1 presidential run-off with 50.89% votes, narrowly defeating the liberal Mayor of Warsaw, Rafal Trzaskowski, who secured 49.11%. Mr. Nawrocki, endorsed by Donald Trump and his MAGA movement, presented himself as an outsider populist, and promised a 'Poland first' approach that echoed Trumpian rhetoric. During its rule (2015–23), the PiS had implemented sweeping reforms that were aimed at tightening its control over state institutions and media, and recasting the Polish society along its ideological lines. It curbed abortion rights, overhauled education and filled the judiciary with party loyalists, often clashing with the European Union. Mr. Tusk attempted to roll back some of these measures, but met with strong opposition from the outgoing President, Andrzej Duda, also a PiS ally. As legislative logjam derailed Mr. Tusk's reform agenda, Mr. Nawrocki capitalised on public resentment, attacking the Polish establishment and Brussels.
While Poland's presidency is largely ceremonial, Mr. Nawrocki's victory could significantly impact its politics. First, the President can veto laws passed by Parliament or send them to the constitutional court, now packed with judges appointed by the PiS government. In a post-election rally, Mr. Nawrocki said the Tusk government was trying to achieve a 'monopoly' of power and vowed to prevent it, in a sign of what is to come. As the government does not have the three-fifths majority in Parliament to override presidential vetoes, Mr. Tusk could face further gridlock. Second, Mr. Nawrocki's victory is a morale boost for Poland's Eurosceptic right and may strengthen the alliance between the populist movements across the Atlantic. Despite his campaign rhetoric to oppose Ukraine joining NATO, he is unlikely to change Poland's foreign policy core — be it its political and security alliance with the West or its opposition to Russia. But on social and economic policies, he is likely to follow the PiS's right-wing conservatism. Third, the election result could exacerbate internal tensions within Mr. Tusk's ideologically broad coalition which threaten to reduce Mr. Tusk to being a lame duck Prime Minister. All this points to a turbulent phase for Poland, where a politically polarised and socially divided nation braces for a prolonged tug of war between the pro-European centrists and ascendant populist conservatives.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Trump & Melania Face Boos In Dc: 'Les Misérables' Night At Kennedy Center Sparks Uproar
What was meant to be a classy evening at the Kennedy Center turned chaotic as President Donald Trump and First Lady Melania were met with a chorus of boos during their arrival at the Les Misérables performance. As the presidential couple made their entrance in full glam, the crowd's disapproval echoed through the venue. While MAGA supporters quickly tried to cover it up with loud 'USA' chants, the moment was already recorded and rapidly went viral across social media. Internet reactions exploded, critics hailed it as 'America booing back,' while Trump loyalists claimed the audio was manipulated or even AI-generated. The political divide was on full display, turning a cultural night into a digital battleground.
Mint
an hour ago
- Mint
Trump wants cheaper drugs like Europe has. How it works.
President Donald Trump doesn't just want to bring down prescription drug prices for Americans. He wants European countries to raise them to make up the revenue that drugmakers would lose from his policy. Trump is proposing a so-called most-favored-nation pricing model, which would set U.S. drug prices at the lowest level in other wealthy countries. But the pharmaceutical industry isn't buying into tying drug prices in the U.S. to prices in Europe—at least not knowing the details of the president's proposal. More details about the government's pricing model could come this week. On May 12, Trump directed government health officials to benchmark drug prices to international standards within 30 days. The lobbying group PhRMA, with members including U.S. pharma giants Eli Lilly, Pfizer, Johnson & Johnson, and AbbVie, has argued there are two reasons why U.S. drug prices are high: foreign countries not paying 'their fair share" for medicines, and middlemen such as pharmacy-benefit managers. Today, U.S. drug pricing is largely market driven. It involves negotiations between drug manufacturers, pharmacy-benefit managers, healthcare insurers and providers. European countries do it much differently. Each has its own way of determining drug prices, but most follow one of two broad approaches. The first approach, which Germany and France use, considers the overall clinical effectiveness of a new medicine. How does the new treatment compare to existing ones? Does it have added therapeutic benefits? If the new drug is substantially better, its price would reflect that. A second approach, used by the U.K., the Netherlands, and Sweden, analyzes cost effectiveness. This model not only compares the new drug to existing ones but also assesses the incremental value that the medicine brings to the health system. After the assessments, negotiations between drugmakers and the countries begin. Because many European countries have national health systems, they are in a strong negotiation position. If government negotiators think a medicine is too expensive for its effectiveness, they won't recommend its use. How Trump's MFN policy would work in practice isn't clear. Drug prices would probably be based on list prices in Europe since the prices paid by national health systems, or net prices, are confidential. The president's open-ended directive, laid out in an executive order, has many wondering how the U.S. could raise prices in Europe. Trump has made clear he wants to close the gap between U.S. and international prices, and has suggested he would use tariffs and export controls to achieve his goal. In theory, drugmakers could set list prices higher in Europe as long as it doesn't affect net prices, health policy expert Dr. Huseyin Naci told Barron's. In the U.K., for example, a higher list price could still lower the prices in other European countries. 'So that would still not be an acceptable approach to many other European countries," said Naci, who is associate professor of health policy at the London School of Economics. Overhauling Europe's decades-old pricing approaches would require fundamental changes to their pricing regulations—and there will be 'little appetite or ability" to alter them, Naci added. Cost is another complicating factor. 'Pharmaceutical spending is already one of the top categories of spending in many countries in terms of healthcare expenditure, so there's little room to accommodate higher prices and spending for pharmaceuticals in Europe," according to Naci. How Trump is planning to make Europeans pay more for drugs is the big question. He could use tariffs and trade negotiations as leverage. In early April, the president said a 'major" tax on pharmaceutical imports is coming 'very shortly," however nothing has been announced yet. In a trade agreement with the U.K. a month later, there is a provision on pharmaceuticals that states the U.K. will 'endeavor to improve the overall environment for pharmaceutical companies." What that means in practice still isn't clear. Write to Elsa Ohlen at
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Trump booed, cheered at Kennedy Center while attending 'Les Miserables'
Trump walked the red carpet with the first lady when they arrived at the Kennedy Center, which he's been remaking in his image while excising what he describes as liberal ideology AP Washington The drama in the audience rivalled the spectacle on stage on Wednesday at the Kennedy Center, where President Donald Trump went to the opening night of Les Miserables as he tightens his grip on the venerable performing arts institution. It was his first time attending a show there since his election, and he was booed and cheered as he took his seat alongside first lady Melania Trump. Near the end of the intermission, someone loudly cursed his name, drawing applause. Several drag queens were in the crowd, their presence a protest against Trump's complaints that the Kennedy Center had hosted too many drag shows in the past. Despite the condemnation, the event had a MAGA-does-Broadway feel. Ric Grenell, the Trump-appointed interim leader of the Kennedy Center, was there, as were Vice President JD Vance and his wife, Usha. Before the show began, Attorney General Pam Bondi chatted with guests and Health and Human Services Secretary Robert F. Kennedy Jr. took selfies. Laura Loomer, the conspiracy theorist who has advised Trump on personnel decisions, posted a video from a seat near the stage. Trump walked the red carpet with the first lady when they arrived at the Kennedy Center, which he's been remaking in his image while excising what he describes as liberal ideology. We want to bring it back, and we want to bring it back better than ever, Trump said. The Republican president has a particular affection for Les Miserables, the sprawling musical set in 19th-century France, and has occasionally played its songs at his events. One of them, Do You Hear the People Sing?, is a revolutionary rallying cry inspired by the 1832 rebellion against the French king. The three-hour production featured singing and dancing, with the sounds of explosions and gunfire filling the theatre as protesters and soldiers clashed on stage. For Trump's critics, it was an unnerving echo of what's unfolding in Los Angeles, where Trump has deployed National Guard troops in response to protests over his deportation policies. Someone explain the plot to him," California Gov. Gavin Newsom, a Democrat, wrote on social media. Terry Gee, a bartender, bought his ticket for the show in November and didn't mind Trump's presence. It's his sixth time seeing Les Miserables, and he said, I'm going to enjoy the show regardless." Hannah Watkins, a nurse, only learned that Trump would be there when the Kennedy Center distributed information about extra security and she searched online to see what was happening. I've seen a lot of famous people so far, which is exciting, said Watkins, who had claimed a spot near the VIP entrance with her mother. Honestly, we just like Les Mis' and are excited to be here. Before Trump, presidential involvement in the Kennedy Center's affairs had been limited to naming members to the board of trustees and attending the taping of its annual honours programme in the fall. But after returning to office in January, Trump stunned the arts world by firing the Kennedy Center's longtime director and board and replacing them with loyalists, who then named him as chairman. Trump promised to overhaul its programming, management and even appearance as part of an effort to put his stamp on the national arts scene. His latest moves have upset some of the centre's patrons and performers. In March, the audience booed the Vances after they slipped into upper-level seats to hear the National Symphony Orchestra. Trump appointed Usha Vance to the Kennedy Center board along with Bondi, White House chief of staff Susie Wiles and Fox News Channel hosts Maria Bartiromo and Laura Ingraham, among other supporters. Sales of subscription packages are said to have declined since Trump's takeover, and several touring productions, including Hamilton, have cancelled planned runs at the centre. Actor Issa Rae and musician Rhiannon Giddens scrapped scheduled appearances, and Kennedy Center consultants including musician Ben Folds and singer Renee Fleming resigned. Understudies may have performed in some roles Wednesday night because of boycotts by Les Miserables cast members, but Trump said he wasn't bothered by anyone skipping the performance. I couldn't care less, he said. Since returning to the White House in January, Trump has adopted a more aggressive posture toward the arts. The White House has taken steps to cancel millions of dollars in previously awarded federal humanities grants to arts and culture groups, and Trump's budget blueprint proposed eliminating the National Endowment for the Arts and the National Endowment for the Humanities. Trump has also targeted Smithsonian museums by signing executive orders to restrict their funding and by attempting to fire the director of the National Portrait Gallery. The president characterised previous programming at the Kennedy Center as out of control with rampant political propaganda and said it featured some very inappropriate shows, including a Marxist anti-police performance and lesbian-only Shakespeare. The Kennedy Center, which is supported by government money and private donations, opened in 1971 and for decades has been seen as an apolitical celebration of the arts. It was first conceived in the late 1950s during the administration of Republican President Dwight Eisenhower, who backed a bill from the Democratic-led Congress calling for a National Culture Center. In the early 1960s, Democratic President John F. Kennedy launched a fundraising initiative, and his successor, President Lyndon B. Johnson, signed into law a 1964 bill renaming the project the John F. Kennedy Memorial Center for the Performing Arts. Kennedy had been assassinated the year before.
